Bio-Rad Laboratories, Inc. (BIO)
369.95
+6.45
(+1.77%)
USD |
NYSE |
Oct 23, 16:00
370.15
+0.20
(+0.05%)
Pre-Market: 20:00
Bio-Rad Laboratories Price to Book Value : 1.379 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.379 |
| October 22, 2026 | 1.355 |
| October 21, 2026 | 1.344 |
| October 20, 2026 | 1.321 |
| October 19, 2026 | 1.315 |
| October 16, 2026 | 1.318 |
| October 15, 2026 | 1.360 |
| October 14, 2026 | 1.351 |
| October 13, 2026 | 1.356 |
| October 12, 2026 | 1.358 |
| October 09, 2026 | 1.365 |
| October 08, 2026 | 1.343 |
| October 07, 2026 | 1.371 |
| October 06, 2026 | 1.375 |
| October 05, 2026 | 1.416 |
| October 02, 2026 | 1.376 |
| October 01, 2026 | 1.325 |
| September 30, 2026 | 1.408 |
| September 29, 2026 | 1.415 |
| September 28, 2026 | 1.408 |
| September 25, 2026 | 1.42 |
| September 24, 2026 | 1.444 |
| September 23, 2026 | 1.412 |
| September 22, 2026 | 1.415 |
| September 21, 2026 | 1.406 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.403 |
| September 17, 2026 | 1.425 |
| September 16, 2026 | 1.413 |
| September 15, 2026 | 1.409 |
| September 14, 2026 | 1.374 |
| September 11, 2026 | 1.376 |
| September 10, 2026 | 1.374 |
| September 09, 2026 | 1.405 |
| September 08, 2026 | 1.417 |
| September 04, 2026 | 1.439 |
| September 03, 2026 | 1.446 |
| September 02, 2026 | 1.448 |
| September 01, 2026 | 1.420 |
| August 31, 2026 | 1.439 |
| August 28, 2026 | 1.445 |
| August 27, 2026 | 1.453 |
| August 26, 2026 | 1.448 |
| August 25, 2026 | 1.455 |
| August 24, 2026 | 1.423 |
| August 21, 2026 | 1.416 |
| August 20, 2026 | 1.403 |
| August 19, 2026 | 1.358 |
| August 18, 2026 | 1.314 |
| August 17, 2026 | 1.324 |
| August 14, 2026 | 1.328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Thermo Fisher Scientific, Inc. | 4.730 |
| Danaher Corp. | 3.024 |
| Agilent Technologies, Inc. | 6.628 |
| Illumina, Inc. | 14.33 |
| Revvity, Inc. | 2.451 |
Price to Book Value Related Metrics
| PE Ratio | 44.82 |
| PS Ratio | 3.847 |
| Price to Free Cash Flow | 28.21 |
| Price | 369.95 |
| Earnings Yield | 2.23% |
| Market Cap | 9.892B |
| Operating PE Ratio | 42.39 |
| Normalized PE Ratio | 57.67 |